期刊文献+

慢性肾衰竭患者血清脂蛋白(a)变化及其临床意义探讨 被引量:1

Changes and clinical significance of lipoprotein(a) in patients with chronic renal failure
下载PDF
导出
摘要 目的观察慢性肾衰竭(CRF)患者血清脂蛋白(a)〔LP(a)〕水平的变化及其与心脑血管疾病的关系。方法回顾分析102例慢性肾衰竭患者的临床及实验室资料,探讨患者血LP(a)水平与心脑血管疾病的关系。结果 CRF患者无论透析与否,其血LP(a)水平均较健康对照组显著升高(P<0.05),血液透析组(HD组)LP(a)水平升高及高密度脂蛋白(HDL-C)水平下降比非透析组(ND)更明显(P<0.01),而HD组与ND组患者血总胆固醇(CHOL)、低密度脂蛋白(LDL-C)、三酰甘油(TG)浓度差异无统计学意义。CRF伴心脑血管疾病患者的血LP(a)水平比无心脑血管疾病患者明显升高(P<0.05)。结论 CRF患者存在严重的脂代谢紊乱,血LP(a)水平升高可能伴随纤溶功能的低下,可能是CRF患者并发心脑血管疾病的危险因素之一。 Objective To observe the changes of hpoprotein(a) [ lp(a) ] in patients with chronic renal failure (CRF) and analyze its relation with cardiocerebral disease. Methods The clinical and laboratory data of 102 patients with CRF were collected and analyzed. The correlation between Lp (a) and cardiocerebral disease was investigated. Results The average level of serum Lp (a) in CRF patients was significantly higher than that in control group(P 〈0.01 ). The average level of serum HDL-C in HD group was significantly lower than that in control group(P 〈0.01 ). No difference was found in serum TG,LDL-C,CHOL between HD group and non-HD group. The serum Lp (a) level was positively correlated with cardiocerebral disease. Conclusion Disorder of lipid metabolism exist in CRF patients. The markedly elevated level of Lp(a) in CRF patients indicates that the renal function may have the effect on the metabolism of Lp(a). The increased synthesis of LP(a) by liver which is stimulated by the low plasma level of albumin may contribute to the high level of LP(a) in patients with CRF. Serum level of LP(a) is positively correlated with and clinical manifestations. LP(a) may be a risk factor of cardiacocerebral disease.
出处 《内科》 2012年第5期465-467,共3页 Internal Medicine
关键词 肾衰竭 慢性 血清脂蛋白(a)[LP(a)] 心脑血管疾病 Renal failure, chronic Lipoprotein(a) Cardiacocerebral disease
  • 相关文献

参考文献5

二级参考文献31

  • 1陈国生.试论清前期云南农业区域[J].中国历史地理论丛,1996,11(3):158-172. 被引量:3
  • 2张步延,宋长杰,周毅,王瑞英.老年脑血管病人Lp(a)及其他脂类水平的观察[J].实用老年医学,1994,8(2):72-73. 被引量:1
  • 3周美华,郭新荣,孟凡迅,吴嘉渔.脂蛋白(a)异常与动脉粥样硬化性疾病的关系探讨[J].实用老年医学,1994,8(1):17-18. 被引量:3
  • 4曾石养,苏卫东,薛志强.终末期肾衰竭透析患者血脂变化的临床意义[J].现代医药卫生,2006,22(15):2260-2261. 被引量:4
  • 5Scanu AM. The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predietor of eoronary heart disease events [J]. Curr Cardiol Rep, 2001,3(5) :385-390.
  • 6Iliescu EA, Marcovina SM, Morton AR, et al. Apolipoprotein(a) phenotype and lipoprotein(a) level predict preritoneal dialysis patient mortality[J]. Perit Dial Int, 2002,22 (4) :492-499.
  • 7Nakamura S,Sasaki O, Nakahama H, et al. Clinical characteristics and survival in end- stage renal disease patients with arteriosclerosis obliterans[J]. Am J Nephrol, 2002,22(5-6) :422-428.
  • 8Kronenbery F,Trenkwalder E, Lingenhel A,et al. Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation[J].J Lipid Res,1997,38(9) :1755-1763.
  • 9Stenvinkel P, Heimburger O,Tuck CH, et al. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure[J]. Kidney Int, 1998,53 (5) : 1336-1342.
  • 10Gotto AM. The new cholesterol education imperative and some comments on niacin[J]. Am J Cardiol, 1998,81(4):492-494.

共引文献76

同被引文献14

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部